LivaNova (LIVN) Shareholder's Equity Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.12% |
| Dec 31, 2025 | -9.11% |
| Sep 30, 2025 | -11.66% |
| Jun 30, 2025 | -9.63% |
| Mar 31, 2025 | -15.33% |
| Dec 31, 2024 | 3.34% |
| Sep 30, 2024 | 6.90% |
| Jun 30, 2024 | 0.16% |
| Mar 31, 2024 | -0.47% |
| Dec 31, 2023 | 5.80% |
| Sep 30, 2023 | 6.84% |
| Jun 30, 2023 | -3.23% |
| Mar 31, 2023 | -4.99% |
| Dec 31, 2022 | -6.72% |
| Sep 30, 2022 | -11.74% |
| Jun 30, 2022 | 24.63% |
| Mar 31, 2022 | 22.44% |
| Dec 31, 2021 | 16.71% |
| Sep 30, 2021 | -3.80% |
| Jun 30, 2021 | -22.84% |
| Mar 31, 2021 | -24.24% |
| Dec 31, 2020 | -19.50% |
| Sep 30, 2020 | -9.66% |
| Jun 30, 2020 | -10.12% |
| Mar 31, 2020 | -6.33% |
| Dec 31, 2019 | -8.16% |
| Sep 30, 2019 | -16.23% |
| Jun 30, 2019 | -16.81% |
| Mar 31, 2019 | -18.26% |
| Dec 31, 2018 | -17.34% |
| Sep 30, 2018 | 4,540.08% |
| Jun 30, 2018 | 2,003,508.99% |
| Mar 31, 2018 | 3,309.44% |
| Dec 31, 2017 | 6.35% |
| Sep 30, 2017 | 1,462.70% |
| Jun 30, 2017 | 99.64% |
| Mar 31, 2017 | -756.78% |
| Dec 31, 2016 | -5.77% |
| Oct 18, 2015 | 3.15% |
| Apr 24, 2015 | 6.74% |